Circadian chronopharmacology

Annual Review of Pharmacology
A Reinberg, F Halberg

Abstract

No abstract listed.

Citations

Dec 17, 1976·Archives of Toxicology·H Mayersbach
Dec 17, 1976·Archives of Toxicology·A Reinberg
Jan 1, 1982·Psychopharmacology·A Campbell, R J Baldessarini
Mar 29, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·A Reinberg, M A Reinberg
Dec 1, 1978·European Journal of Clinical Pharmacology·A ReinbergA Nicolai
Jan 31, 1978·Psychopharmacology·R HawkinsD S Janowsky
Jan 1, 1981·European Journal of Clinical Pharmacology·J ClenchM Smolensky
Jan 1, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·B Lemmer, R Saller
Mar 1, 1979·International Journal of Biometeorology·O HérouxM Normand
Nov 1, 1979·Bulletin of Environmental Contamination and Toxicology·D J McLeay, J R Munro
Jul 1, 1983·European Journal of Drug Metabolism and Pharmacokinetics·B BruguerolleP Bouyard
Jan 1, 1981·European Journal of Drug Metabolism and Pharmacokinetics·B BruguerolleP Bouyard
Feb 1, 1990·Biological Psychiatry·F M Jacobsen
Dec 9, 1982·Brain Research·S Puglisi-AllegraA Oliverio
Jul 1, 1982·Neuropharmacology·A CampbellR J Baldessarini
Jul 1, 1979·Physiology & Behavior·J A Walker, D S Olton
Nov 1, 1981·Physiology & Behavior·M FukushimaC Asano
Mar 1, 1980·Pharmacology, Biochemistry, and Behavior·S NakanoN Ogawa
Dec 1, 1982·Pharmacology, Biochemistry, and Behavior·H Kuribara, S Tadokoro
May 1, 1983·Pharmacology, Biochemistry, and Behavior·D M Gilliam, A C Collins
Jan 1, 1983·Pharmacology & Therapeutics·A Reinberg, M Smolensky
Mar 1, 1975·Bio Systems·T V Driessche
Jan 1, 1980·Behavioral and Neural Biology·S S MoskoR Y Moore
Sep 1, 1983·The New England Journal of Medicine·M C Moore-EdeG S Richardson
Jun 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yoichi MinamiHiroki R Ueda
Aug 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·Takeya KasukawaHiroki R Ueda
Nov 28, 2012·International Journal of Epidemiology·Robert CarrollMichael Eddleston
May 7, 2002·Behavioural Pharmacology·A K KemmlingG N Balerio
Nov 1, 1974·The Journal of Obstetrics and Gynaecology of the British Commonwealth·I D Smith, R P Shearman
Jan 1, 1975·Nursing Forum·M L O'Dell
Jan 1, 1991·Annals of the New York Academy of Sciences·A E Reinberg
Jan 1, 1991·Annals of the New York Academy of Sciences·C J Carr
Jan 11, 2007·Annual Review of Pharmacology and Toxicology·Francis Levi, Ueli Schibler
Nov 13, 2004·Genome Biology·Urs Albrecht
Feb 2, 2010·Biological & Pharmaceutical Bulletin·Shigehiro Ohdo
Dec 1, 1975·Environmental Health Perspectives·L W ReiterD F Cahill
Oct 1, 1976·Environmental Health Perspectives·M Stupfel
Oct 1, 1978·Environmental Health Perspectives·L Reiter
Apr 15, 2014·Theoretical Biology & Medical Modelling·Germaine Cornelissen
Jul 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hiroki R UedaSeiichi Hashimoto
Sep 1, 1981·Archives of Toxicology·K PüschelH von Mayersbach

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.